null result

  1. Dolphin

    Health outcomes of patients in the Complex Chronic Diseases Program, 2025, Meagher, Nacul, et al.

    Start on page 174 BC MEDICAL JOURNAL VOL. 67 NO. 5 | JUNE 2025 https://bcmj.org/sites/default/files/BCMJ_Vol67_No5_complete.pdf Health outcomes of patients in the Complex Chronic Diseases Program New approaches and research are urgently needed to improve therapeutic interventions for...
  2. Andy

    Review Efficacy of Low-Dose Naltrexone in Treating Patients with Fibromyalgia: systematic Review and Meta-Analysis 2025 Ologunowa et al

    Abstract Low-dose naltrexone (LDN) has demonstrated mixed efficacy in treating fibromyalgia. This systematic review and meta-analysis aimed to evaluate the efficacy of LDN for fibromyalgia. We systematically searched electronic databases and gray literature from inception to May 2024. Included...
  3. SNT Gatchaman

    Trial Report Ten sessions of hyperbaric oxygen versus sham treatment in patients with long covid HOT-LoCO…, 2025, Kjellberg et al.

    Ten sessions of hyperbaric oxygen versus sham treatment in patients with long covid HOT-LoCO: a randomised, placebo-controlled, double-blind, phase II trial Anders Kjellberg; Adrian Hassler; Emil Boström; Sara El Gharbi; Sarah Al-Ezerjawi; Anna Schening; Katarina Fischer; Jan H Kowalski; Kenny A...
  4. SNT Gatchaman

    Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA PAX LC, 2025, Sawano, Iwasaki+

    Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA PAX LC: a double-blind, randomised, placebo-controlled, phase 2, decentralised trial Mitsuaki Sawano; Bornali Bhattacharjee; César Caraballo; Rohan Khera; Shu-Xia Li; Jeph Herrin; Dany Christian; Andreas...
  5. SNT Gatchaman

    Addressing post-COVID-19 musculoskeletal symptoms through pulmonary rehabilitation with an evidence-based eHealth education tool, 2025,Sánchez-Romero+

    Addressing post-COVID-19 musculoskeletal symptoms through pulmonary rehabilitation with an evidence-based eHealth education tool: Preliminary results from a pilot randomized controlled clinical trial Sánchez-Romero, Eleuterio A.; García-Barredo-Restegui, Teresa; Martínez-Rolando, Lidia...
  6. SNT Gatchaman

    Preliminary evaluation of a mindfulness intervention program in women with long COVID dysautonomia symptoms, 2025, Vandenbogaart+

    Preliminary evaluation of a mindfulness intervention program in women with long COVID dysautonomia symptoms Vandenbogaart; Figueroa; Winston; Cole; Bower; Hsu BACKGROUND The symptom burden for patients with Long COVID-associated dysautonomia is high, yet there are currently no effective...
  7. SNT Gatchaman

    Trial Report Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial, 2025, España-Cueto+

    Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial España-Cueto, Sergio; Loste, Cora; Lladós, Gemma; López, Cristina; Santos, José Ramón; Dulsat, Gemma; García, Anna; Carmezim, João; Carabia, Julia; Ancochea, Águeda...
  8. SNT Gatchaman

    Trial Report Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction: A Randomized Clinical Trial, 2024, Guttuso et al.

    Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction: A Randomized Clinical Trial Thomas Guttuso; Jingtao Zhu; Gregory E. Wilding IMPORTANCE Neurologic post–COVID-19 condition (PCC), or long COVID, symptoms of fatigue and cognitive dysfunction continue to affect millions of people...
  9. SNT Gatchaman

    Follow-up of patients with post covid-19 condition after a multidisciplinary team assessment: a pilot study, 2024, Wigge et al.

    Follow-up of patients with post covid-19 condition after a multidisciplinary team assessment: a pilot study Alexander Wigge; Johanna Philipson; Solveig Hällgren; Helena Filipsson; Britt-Marie Stålnacke OBJECTIVES To follow up patients with post-COVID-19 condition (PCC) 6 months after a...
  10. SNT Gatchaman

    Differentiation of Prior SARS-CoV-2 Infection and [PASC] by Standard Clinical Laboratory Measurements in the RECOVER Cohort, 2024, Erlandson+

    Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort 60 authors ; on behalf of the RECOVER-Adult Cohort BACKGROUND There are currently no validated clinical biomarkers of postacute sequelae of SARS-CoV-2...
  11. Andy

    Trial Report Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD):... 2024 Nielsen, Stone, Carson, Edwards et al

    One trial has resulted in three papers. As well as this main paper, there is: Which factors predict outcome from specialist physiotherapy for functional motor disorder?... 2025, Nielsen, Stone, Carson, Edwards et al Cost Utility of Specialist Physiotherapy for Functional Motor Disorder...
  12. SNT Gatchaman

    Trial Report Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection PASC, 2024, Andrews et al.

    Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection PASC: A Randomized Phase 2 Trial of RSLV-132 Andrews, James S; Boonyaratanakornkit, Jim B; Krusinska, Eva; Allen, Suzanne; Posada, James A BACKGROUND Severe acute respiratory...
  13. SNT Gatchaman

    A Comprehensive and Broad Approach to Resting-State Functional Connectivity in Adult Patients with Mild Traumatic Brain Injury, 2024, Arabshahi et al.

    A Comprehensive and Broad Approach to Resting-State Functional Connectivity in Adult Patients with Mild Traumatic Brain Injury Soroush Arabshahi; Sohae Chung; Alaleh Alivar; Prin X. Amorapanth; Steven R. Flanagan; Farng-Yang A. Foo; Andrew F. Laine; Yvonne W. Lui BACKGROUND AND PURPOSE Several...
  14. SNT Gatchaman

    Use of testosterone replacement therapy to treat long-COVID-related hypogonadism, 2024, Amodeo et al.

    Use of testosterone replacement therapy to treat long-COVID-related hypogonadism Alessandro Amodeo; Luca Persani; Marco Bonomi; Biagio Cangiano Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can impair pituitary–gonadal axis and a higher prevalence of hypogonadism in...
  15. SNT Gatchaman

    Graded exercise therapy compared to activity management for paediatric [CFS/ME]: pragmatic randomized controlled trial, 2024, Gaunt, Crawley et al.

    Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trial Gaunt, Daisy M.; Brigden, Amberly; Harris, Shaun R. S.; Hollingworth, William; Jago, Russell; Solomon-Moore, Emma; Beasant, Lucy...
  16. Sid

    Trial Report Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND)

    Abstract Objective: This study assesses response to intravenous immunoglobulin (IVIG) in presumed autoimmune postural orthostatic tachycardia syndrome (POTS). Background: POTS may be associated with autoimmune disorders, serum autoantibodies, or recent infection. Uncontrolled case studies...
  17. SNT Gatchaman

    Trial Report Transcranial direct current stimulation tDCS in the treatment of neuropsychiatric symptoms of long COVID, 2024, Klírová et al.

    Transcranial direct current stimulation tDCS in the treatment of neuropsychiatric symptoms of long COVID Klírová, Monika; Adamová, Andrea; Biačková, Nina; Laskov, Olga; Renková, Veronika; Stuchlíková, Zuzana; Odnohová, Karolína; Novák, Tomáš The study aimed to assess the efficacy of...
  18. SNT Gatchaman

    Confirmation of COVID-19 infection status & reporting of [LC] symptoms in a population-based birth cohort: No evidence of a nocebo effect, 2024

    Confirmation of COVID-19 infection status and reporting of Long COVID symptoms in a population-based birth cohort: No evidence of a nocebo effect Catherine IA Macleod-Hall; Marcus R Munafò; Maddy L Dyer Some patients with COVID-19 develop symptoms after the acute infection, known as ‘Long...
  19. SNT Gatchaman

    Trial Report Retinal Microvasculature Image Analysis Using Optical Coherence Tomography Angiography in Patients with Post-COVID-19 Syndrome, 2023, Noor et al.

    Retinal Microvasculature Image Analysis Using Optical Coherence Tomography Angiography in Patients with Post-COVID-19 Syndrome, 2023, Noor et al. Retinal Microvasculature Image Analysis Using Optical Coherence Tomography Angiography in Patients with Post-COVID-19 Syndrome Noor, Maha; McGrath...
  20. SNT Gatchaman

    Examination of autoantibodies to type I interferon in patients suffering from long COVID, 2023, Hansen et al.

    Examination of autoantibodies to type I interferon in patients suffering from long COVID Kristoffer Skaalum Hansen; Sofie Eg Jørgensen; Morten Kelder Skouboe; Jane Agergaard; Berit Schiøttz-Christensen; Line Khalidan Vibholm; Martin Tolstrup; Lars Østergaard; Steffen Leth; Trine H. Mogensen...
Back
Top Bottom